Clinical Trial Update: GCB-001 in Treatment of Patients With Type II (SMA) Spinal Muscular Atrophy [NA]

View source ↗

Summary

This trial update states that GCB-001 for spinal muscular atrophy type 2 is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Muscular Atrophy

Drugs mentioned

• GCB-001

Snippet

Sponsor: Genecombio Ltd. | Conditions: Spinal Muscular Atrophy Type 2 | NA | Status: ENROLLING_BY_INVITATION